Exosens
EXENS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €394 | €319 | €201 | €166 |
| % Growth | 23.6% | 58.8% | 20.8% | – |
| Cost of Goods Sold | €169 | €142 | €87 | €66 |
| Gross Profit | €226 | €177 | €114 | €100 |
| % Margin | 57.2% | 55.5% | 56.8% | 60.2% |
| R&D Expenses | €0 | €9 | €4 | €6 |
| G&A Expenses | €113 | €83 | €63 | €57 |
| SG&A Expenses | €115 | €85 | €65 | €58 |
| Sales & Mktg Exp. | €2 | €2 | €1 | €1 |
| Other Operating Expenses | €34 | €28 | -€47 | €4 |
| Operating Expenses | €149 | €122 | €21 | €68 |
| Operating Income | €77 | €55 | €30 | €32 |
| % Margin | 19.5% | 17.3% | 15.2% | 19.2% |
| Other Income/Exp. Net | -€35 | -€36 | -€13 | -€182 |
| Pre-Tax Income | €42 | €19 | €17 | -€150 |
| Tax Expense | €11 | €2 | €6 | -€1 |
| Net Income | €31 | €17 | €11 | -€149 |
| % Margin | 7.8% | 5.4% | 5.6% | -89.6% |
| EPS | 0.6 | 0.56 | 0.37 | -4.9 |
| % Growth | 7.1% | 51.4% | 107.6% | – |
| EPS Diluted | 0.6 | 0.56 | 0.37 | -4.9 |
| Weighted Avg Shares Out | 51 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 51 | 30 | 30 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €1 | €0 | €0 |
| Interest Expense | €28 | €31 | €15 | €38 |
| Depreciation & Amortization | €38 | €34 | €19 | €11 |
| EBITDA | €115 | €84 | €51 | -€101 |
| % Margin | 29.2% | 26.3% | 25.5% | -60.9% |